1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of ARL6IP5 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARL6IP5 mRNA CTD PMID:22206623 17beta-estradiol affects expression ISO ARL6IP5 (Homo sapiens) 6480464 Estradiol affects the expression of ARL6IP5 mRNA CTD PMID:14699072 17beta-estradiol decreases expression ISO ARL6IP5 (Homo sapiens) 6480464 Estradiol results in decreased expression of ARL6IP5 mRNA CTD PMID:23019147 2,2',4,4'-Tetrabromodiphenyl ether affects expression EXP 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ARL6IP5 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Arl6ip5 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ARL6IP5 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Arl6ip5 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of ARL6IP5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ARL6IP5 mRNA CTD PMID:15034205 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ARL6IP5 mRNA CTD PMID:25975270 2-hydroxypropanoic acid increases expression ISO ARL6IP5 (Homo sapiens) 6480464 Lactic Acid results in increased expression of ARL6IP5 mRNA CTD PMID:30851411 2-methylcholine affects expression ISO ARL6IP5 (Homo sapiens) 6480464 beta-methylcholine affects the expression of ARL6IP5 mRNA CTD PMID:21179406 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of ARL6IP5 mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol increases expression ISO ARL6IP5 (Homo sapiens) 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ARL6IP5 protein CTD PMID:34186270 4-hydroxyphenyl retinamide affects expression ISO ARL6IP5 (Homo sapiens) 6480464 Fenretinide affects the expression of ARL6IP5 CTD PMID:16720286 5-aza-2'-deoxycytidine affects expression ISO ARL6IP5 (Homo sapiens) 6480464 Decitabine affects the expression of ARL6IP5 mRNA CTD PMID:23300844 5-fluorouracil multiple interactions ISO ARL6IP5 (Homo sapiens) 6480464 ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Cisplatin] and ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin] CTD PMID:22452940 5-formyltetrahydrofolic acid multiple interactions ISO ARL6IP5 (Homo sapiens) 6480464 ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Cisplatin] and ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin] CTD PMID:22452940 6-propyl-2-thiouracil decreases expression ISO Arl6ip5 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of ARL6IP5 mRNA CTD PMID:24780913 7,12-dimethyltetraphene multiple interactions EXP 6480464 [9 more ... CTD PMID:32553695 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:32553695 acetylsalicylic acid increases expression ISO ARL6IP5 (Homo sapiens) 6480464 Aspirin results in increased expression of ARL6IP5 mRNA CTD PMID:15928584 all-trans-retinoic acid multiple interactions ISO ARL6IP5 (Homo sapiens) 6480464 [Tretinoin co-treated with arsenic trioxide] results in increased expression of ARL6IP5 mRNA more ... CTD PMID:16468075 and PMID:16922813 all-trans-retinoic acid increases expression ISO ARL6IP5 (Homo sapiens) 6480464 Tretinoin results in increased expression of ARL6IP5 mRNA and Tretinoin results in increased expression of ARL6IP5 protein CTD PMID:16430862 more ... all-trans-retinoic acid affects expression ISO ARL6IP5 (Homo sapiens) 6480464 Tretinoin affects the expression of ARL6IP5 CTD PMID:16720286 all-trans-retinoic acid increases response to substance ISO ARL6IP5 (Homo sapiens) 6480464 ARL6IP5 protein results in increased susceptibility to Tretinoin CTD PMID:16922813 ammonium chloride affects expression ISO Arl6ip5 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of ARL6IP5 mRNA CTD PMID:16483693 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of ARL6IP5 mRNA CTD PMID:25270620 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of ARL6IP5 mRNA CTD PMID:15894712 arsenite(3-) multiple interactions EXP 6480464 [arsenite co-treated with Benzo(a)pyrene] results in increased expression of ARL6IP5 mRNA CTD PMID:15894712 arsenous acid increases response to substance ISO ARL6IP5 (Homo sapiens) 6480464 ARL6IP5 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:18387645 arsenous acid multiple interactions ISO ARL6IP5 (Homo sapiens) 6480464 [Arsenic Trioxide results in increased abundance of Hydrogen Peroxide] which results in increased expression of ARL6IP5 protein more ... CTD PMID:16468075 and PMID:18387645 arsenous acid increases expression ISO ARL6IP5 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of ARL6IP5 protein CTD PMID:16430862 benzene-1,2,4-triol decreases expression ISO ARL6IP5 (Homo sapiens) 6480464 hydroxyhydroquinone results in decreased expression of ARL6IP5 mRNA CTD PMID:17572062 benzo[a]pyrene multiple interactions EXP 6480464 [arsenite co-treated with Benzo(a)pyrene] results in increased expression of ARL6IP5 mRNA and [Benzo(a)pyrene results in increased activity of AHR protein] which results in increased expression of ARL6IP5 mRNA CTD PMID:15894712 and PMID:32553695 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene metabolite results in increased expression of ARL6IP5 mRNA and Benzo(a)pyrene results in increased expression of ARL6IP5 mRNA CTD PMID:15034205 more ... bexarotene increases expression ISO ARL6IP5 (Homo sapiens) 6480464 bexarotene results in increased expression of ARL6IP5 mRNA CTD PMID:17178900 bisphenol A affects expression ISO Arl6ip5 (Rattus norvegicus) 6480464 bisphenol A affects the expression of ARL6IP5 mRNA CTD PMID:25181051 bisphenol A increases expression ISO ARL6IP5 (Homo sapiens) 6480464 bisphenol A results in increased expression of ARL6IP5 protein CTD PMID:33376534 and PMID:34186270 bisphenol A decreases expression ISO Arl6ip5 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of ARL6IP5 mRNA CTD PMID:30816183 and PMID:32528016 Bisphenol B increases expression ISO ARL6IP5 (Homo sapiens) 6480464 bisphenol B results in increased expression of ARL6IP5 protein CTD PMID:34186270 bisphenol F increases expression ISO ARL6IP5 (Homo sapiens) 6480464 bisphenol F results in increased expression of ARL6IP5 protein CTD PMID:34186270 Brodifacoum increases expression ISO Arl6ip5 (Rattus norvegicus) 6480464 bromfenacoum results in increased expression of ARL6IP5 protein CTD PMID:28903499 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 chloropicrin increases expression ISO ARL6IP5 (Homo sapiens) 6480464 chloropicrin results in increased expression of ARL6IP5 mRNA CTD PMID:26352163 cisplatin affects expression ISO ARL6IP5 (Homo sapiens) 6480464 Cisplatin affects the expression of ARL6IP5 mRNA CTD PMID:23300844 cisplatin multiple interactions ISO ARL6IP5 (Homo sapiens) 6480464 ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Cisplatin] CTD PMID:22452940 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of ARL6IP5 mRNA CTD PMID:17585979 copper atom decreases expression ISO Arl6ip5 (Rattus norvegicus) 6480464 Copper results in decreased expression of ARL6IP5 mRNA CTD PMID:30556269 copper(0) decreases expression ISO Arl6ip5 (Rattus norvegicus) 6480464 Copper results in decreased expression of ARL6IP5 mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO ARL6IP5 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of ARL6IP5 mRNA CTD PMID:19549813 Cuprizon decreases expression ISO Arl6ip5 (Rattus norvegicus) 6480464 Cuprizone results in decreased expression of ARL6IP5 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO ARL6IP5 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of ARL6IP5 mRNA CTD PMID:20106945 and PMID:25562108 cytarabine increases expression ISO ARL6IP5 (Homo sapiens) 6480464 Cytarabine results in increased expression of ARL6IP5 protein CTD PMID:16430862 diarsenic trioxide increases response to substance ISO ARL6IP5 (Homo sapiens) 6480464 ARL6IP5 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:18387645 diarsenic trioxide increases expression ISO ARL6IP5 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of ARL6IP5 protein CTD PMID:16430862 diarsenic trioxide multiple interactions ISO ARL6IP5 (Homo sapiens) 6480464 [Arsenic Trioxide results in increased abundance of Hydrogen Peroxide] which results in increased expression of ARL6IP5 protein more ... CTD PMID:16468075 and PMID:18387645 dibutyl phthalate decreases expression ISO Arl6ip5 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in decreased expression of ARL6IP5 mRNA CTD PMID:21266533 dicrotophos decreases expression ISO ARL6IP5 (Homo sapiens) 6480464 dicrotophos results in decreased expression of ARL6IP5 mRNA CTD PMID:28302478 diuron decreases expression ISO ARL6IP5 (Homo sapiens) 6480464 Diuron results in decreased expression of ARL6IP5 mRNA CTD PMID:35967413 doxorubicin increases expression ISO ARL6IP5 (Homo sapiens) 6480464 Doxorubicin results in increased expression of ARL6IP5 protein CTD PMID:16430862 etoposide decreases expression ISO ARL6IP5 (Homo sapiens) 6480464 Etoposide results in decreased expression of ARL6IP5 CTD PMID:19492242 etoposide increases response to substance ISO ARL6IP5 (Homo sapiens) 6480464 ARL6IP5 protein results in increased susceptibility to Etoposide CTD PMID:19492242 fipronil increases expression ISO Arl6ip5 (Rattus norvegicus) 6480464 fipronil results in increased expression of ARL6IP5 mRNA CTD PMID:31881178 flutamide increases expression ISO Arl6ip5 (Rattus norvegicus) 6480464 Flutamide results in increased expression of ARL6IP5 mRNA CTD PMID:24136188 folic acid multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARL6IP5 mRNA CTD PMID:22206623 gentamycin increases expression ISO Arl6ip5 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of ARL6IP5 mRNA CTD PMID:22061828 and PMID:33387578 hemin increases expression ISO ARL6IP5 (Homo sapiens) 6480464 Hemin results in increased expression of ARL6IP5 protein CTD PMID:16430862 hydralazine multiple interactions ISO ARL6IP5 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of ARL6IP5 mRNA CTD PMID:17183730 hydrogen peroxide multiple interactions ISO ARL6IP5 (Homo sapiens) 6480464 [arsenic trioxide results in increased abundance of Hydrogen Peroxide] which results in increased expression of ARL6IP5 protein and CAT protein inhibits the reaction [[arsenic trioxide results in increased abundance of Hydrogen Peroxide] which results in increased expression of ARL6IP5 protein] CTD PMID:18387645 ivermectin decreases expression ISO ARL6IP5 (Homo sapiens) 6480464 Ivermectin results in decreased expression of ARL6IP5 protein CTD PMID:32959892 kojic acid increases expression ISO ARL6IP5 (Homo sapiens) 6480464 kojic acid results in increased expression of ARL6IP5 mRNA CTD PMID:16595896 Mesaconitine decreases expression ISO Arl6ip5 (Rattus norvegicus) 6480464 mesaconitine results in decreased expression of ARL6IP5 protein CTD PMID:37182599 methylmercury chloride decreases expression ISO ARL6IP5 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of ARL6IP5 mRNA CTD PMID:23179753 morphine multiple interactions ISO ARL6IP5 (Homo sapiens) 6480464 ARL6IP5 mutant form inhibits the reaction [Morphine results in increased expression of OPRD1 protein] more ... CTD PMID:21600884 morphine increases expression ISO Arl6ip5 (Rattus norvegicus) 6480464 Morphine results in increased expression of ARL6IP5 protein CTD PMID:21600884 morphine multiple interactions ISO Arl6ip5 (Rattus norvegicus) 6480464 ARL6IP5 mutant form inhibits the reaction [Morphine results in increased expression of OPRD1 protein] more ... CTD PMID:21600884 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO Arl6ip5 (Rattus norvegicus) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [ARL6IP5 mutant form inhibits the reaction [Morphine results in increased expression of OPRD1 protein]] CTD PMID:21600884 nickel subsulfide increases expression ISO Arl6ip5 (Rattus norvegicus) 6480464 nickel subsulfide results in increased expression of ARL6IP5 mRNA CTD PMID:21086188 oxaliplatin multiple interactions ISO ARL6IP5 (Homo sapiens) 6480464 ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin] CTD PMID:22452940 ozone multiple interactions ISO ARL6IP5 (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of ARL6IP5 mRNA CTD PMID:35430440 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of ARL6IP5 mRNA CTD PMID:17562736 paracetamol decreases expression ISO Arl6ip5 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of ARL6IP5 mRNA CTD PMID:33387578 paracetamol decreases expression ISO ARL6IP5 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of ARL6IP5 mRNA CTD PMID:21420995 and PMID:29067470 paraquat increases expression EXP 6480464 Paraquat results in increased expression of ARL6IP5 CTD PMID:28428137 paraquat multiple interactions ISO ARL6IP5 (Homo sapiens) 6480464 ARL6IP5 protein affects the reaction [Paraquat affects the expression of NFE2L2 protein] more ... CTD PMID:28428137 paraquat multiple interactions EXP 6480464 ARL6IP5 protein affects the reaction [Paraquat affects the expression of NFE2L2 protein] more ... CTD PMID:28428137 paraquat affects response to substance EXP 6480464 ARL6IP5 protein affects the susceptibility to Paraquat CTD PMID:28428137 paraquat increases expression ISO ARL6IP5 (Homo sapiens) 6480464 Paraquat results in increased expression of ARL6IP5 protein CTD PMID:28428137 parathion decreases expression EXP 6480464 Parathion results in decreased expression of ARL6IP5 mRNA CTD PMID:34813904 perfluorooctanoic acid decreases expression ISO ARL6IP5 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of ARL6IP5 protein CTD PMID:26879310 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of ARL6IP5 mRNA CTD PMID:19270015 phorbol 13-acetate 12-myristate multiple interactions ISO ARL6IP5 (Homo sapiens) 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [Tretinoin results in increased expression of ARL6IP5 mRNA] CTD PMID:16468075 phorbol 13-acetate 12-myristate increases expression ISO ARL6IP5 (Homo sapiens) 6480464 Tetradecanoylphorbol Acetate results in increased expression of ARL6IP5 protein CTD PMID:16430862 phoxim affects expression ISO ARL6IP5 (Homo sapiens) 6480464 phoxim affects the expression of ARL6IP5 protein CTD PMID:15799245 piroxicam increases expression ISO ARL6IP5 (Homo sapiens) 6480464 Piroxicam results in increased expression of ARL6IP5 mRNA CTD PMID:21858171 potassium chromate decreases expression ISO ARL6IP5 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of ARL6IP5 mRNA CTD PMID:22714537 quercetin decreases expression ISO ARL6IP5 (Homo sapiens) 6480464 Quercetin results in decreased expression of ARL6IP5 mRNA CTD PMID:21632981 rac-lactic acid increases expression ISO ARL6IP5 (Homo sapiens) 6480464 Lactic Acid results in increased expression of ARL6IP5 mRNA CTD PMID:30851411 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of ARL6IP5 mRNA CTD PMID:23186747 temozolomide decreases expression ISO ARL6IP5 (Homo sapiens) 6480464 Temozolomide results in decreased expression of ARL6IP5 mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO ARL6IP5 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of ARL6IP5 mRNA CTD PMID:15336504 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of ARL6IP5 mRNA CTD PMID:27339419 and PMID:31919559 thioacetamide increases expression ISO Arl6ip5 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of ARL6IP5 mRNA CTD PMID:34492290 trovafloxacin increases expression EXP 6480464 trovafloxacin results in increased expression of ARL6IP5 mRNA CTD PMID:35537566 valproic acid multiple interactions ISO ARL6IP5 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of ARL6IP5 mRNA CTD PMID:17183730 valproic acid increases expression ISO ARL6IP5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of ARL6IP5 mRNA CTD PMID:19101580 more ... valproic acid affects expression ISO ARL6IP5 (Homo sapiens) 6480464 Valproic Acid affects the expression of ARL6IP5 mRNA CTD PMID:25979313 zinc atom decreases expression ISO ARL6IP5 (Homo sapiens) 6480464 Zinc deficiency results in decreased expression of ARL6IP5 mRNA CTD PMID:22171008 zinc(0) decreases expression ISO ARL6IP5 (Homo sapiens) 6480464 Zinc deficiency results in decreased expression of ARL6IP5 mRNA CTD PMID:22171008
